CD45RO enriches for activated, highly mutated human germinal center B cells

Blood

Volumn 110, Issue 12, 2007, Pages 3917-3925

  Jackson, Stephen M ^a   Harp, Natessa ^a   Patel, Darshna ^a   Zhang, Jeffrey ^a   Willson, Savannah ^a   Kim, Yoon J ^a   Clanton, Christian ^a   Capra, J Donald ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CD19 ANTIGEN; CD4 ANTIGEN; CD45RO ANTIGEN; CYTIDINE DEAMINASE; IMMUNOGLOBULIN M; ISOPROTEIN; LEUKOCYTE ANTIGEN; LIPOCORTIN 5;

AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL DIVISION; CELL ISOLATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOMETRY; DNA SEQUENCE; GENE MUTATION; GERMINAL CENTER; HUMAN; HUMAN CELL; LYMPHOCYTE; LYMPHOID CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SEQUENCE ANALYSIS; SOMATIC HYPERMUTATION; T LYMPHOCYTE;

EID: 37049034100     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-05-087767     Document Type: Article

References (55)

1. Alexander DR. The CD45 tyrosine phosphatase: a positive and negative regulator of immune cell function. Semin Immunol. 2000;12:349-359.
2. Holmes N. CD45: all is not yet crystal clear. Immunology. 2006;117:145-155.
3. Huntington ND, Tarlinton DM. CD45: direct and indirect government of immune regulation. Immunol Lett. 2004;94:167-174.
4. McNeill L, Cassady RL, Sarkardei S, Cooper JC, Morgan G, Alexander DR. CD45 isoforms in T cell signalling and development. Immunol Lett. 2004;92:125-134.
5. Matto M, Nuutinen UM, Ropponen A, Myllykangas K, Pelkonen J. CD45RA and RO isoforms have distinct effects on cytokine- and B-cell-receptor-mediated signalling in human B cells. Scand J Immunol. 2005;61:520-528.
6. Tchilian EZ, Dawes R, Hyland L, et al. Altered CD45 isoform expression affects lymphocyte function in CD45 Tg mice. Int Immunol. 2004;16:1323-1332.
7. Fukuhara K, Okumura M, Shiono H, et al. A study on CD45 isoform expression during T-cell development and selection events in the human thymus. Hum Immunol. 2002;63:394-404.
8. Hathcock KS, Hirano H, Hodes RJ. CD45 expression by murine B cells and T cells: alteration of CD45 isoforms in subpopulations of activated B cells. Immunol Res. 1993;12:21-36.
9. Heyd F, ten Dam G, Moroy T. Auxiliary splice factor U2AF26 and transcription factor Gfi1 cooperate directly in regulating CD45 alternative splicing. Nat Immunol. 2006;7:859-867.
10. Sarkissian M, Winne A, Lafyatis R. The mammalian homolog of suppressor-of-white-apricot regulates alternative mRNA splicing of CD45 exon 4 and fibronectin IIICS. J Biol Chem. 1996;271:31106-31114.
11. Lemaire R, Winne A, Sarkissian M, Lafyatis R. SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation. Eur J Immunol. 1999;29:823-837.
12. Ogilvy S, Louis-Dit-Sully C, Cooper J, Cassady RL, Alexander DR, Holmes N. Either of the CD45RB and CD45RO isoforms are effective in restoring T cell, but not B cell, development and function in CD45-null mice. J Immunol. 2003;171:1792-1800.
13. Fleming HE, Milne CD, Paige CJ. CD45-deficient mice accumulate Pro-B cells both in vivo and in vitro. J Immunol. 2004;173:2542-2551.
14. Young JL, Ramage JM, Gaston JS, Beverley PC. In vitro responses of human CD45R0brightRA-and CD45R0-RAbright T cell subsets and their relationship to memory and naive T cells. Eur J Immunol. 1997;27:2383-2390.
15. Deans JP, Serra HM, Shaw J, Shen YJ, Torres RM, Pilarski LM. Transient accumulation and subsequent rapid loss of messenger RNA encoding high molecular mass CD45 isoforms after T cell activation. J Immunol. 1992;148:1898-1905.
16. Kristensson K, Borrebaeck CA, Carlsson R. Human CD4+ T cells expressing CD45RA acquire the lymphokine gene expression of CD45RO+ T-helper cells after activation in vitro. Immunology. 1992;76:103-109.
17. Hamann D, Baars PA, Hooibrink B, van Lier RW. Heterogeneity of the human CD4+ T-cell population: two distinct CD4+ T-cell subsets characterized by coexpression of CD45RA and CD45RO isoforms. Blood. 1996;88:3513-3521.
18. Rodig SJ, Shahsafaei A, Li B, Dorfman DM. The CD45 isoform B220 identifies select subsets of human B cells and B-cell lymphoproliferative disorders. Hum Pathol. 2005;36:51-57.
19. Yu Y, Rabinowitz R, Polliack A, Ben-Bassat H, Schlesinger M. Hyposialated 185 kDa CD45RA+ molecules attain a high concentration in B lymphoma cells and in activated human B cells. Eur J Haematol. 2002;68:22-30.
20. Dawes R, Petrova S, Liu Z, Wraith D, Beverley PC, Tchilian EZ. Combinations of CD45 isoforms are crucial for immune function and disease. J Immunol. 2006;176:3417-3425.
21. Tchilian EZ, Beverley PC. Altered CD45 expression and disease. Trends Immunol. 2006;27:146-153.
22. Novak TJ, Farber D, Leitenberg D, Hong SC, Johnson P, Bottomly K. Isoforms of the transmembrane tyrosine phosphatase CD45 differentially affect T cell recognition. Immunity. 1994;1:109-119.
23. Hermiston ML, Xu Z, Weiss A. CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol. 2003;21:107-137.
24. Cyster JG. Signaling thresholds and interclonal competition in preimmune B-cell selection. Immunol Rev. 1997;156:87-101.
25. Cyster JG, Healy JI, Kishihara K, Mak TW, Thomas ML, Goodnow CC. Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45. Nature. 1996;381:325-328.
26. Huntington ND, Xu Y, Puthalakath H, et al. CD45 links the B cell receptor with cell survival and is required for the persistence of germinal centers. Nat Immunol. 2006;7:190-198.
27. Dahlke MH, Larsen SR, Rasko JE, Schlitt HJ. The biology of CD45 and its use as a therapeutic target. Leuk Lymphoma. 2004;45:229-236.
28. Kolar GR, Mehta D, Wilson PC, Capra JD. Diversity of the Ig repertoire is maintained with age in spite of reduced germinal centre cells in human tonsil lymphoid tissue. Scand J Immunol. 2006;64:314-324.
29. Pascual V, Liu YJ, Magalski A, de Bouteiller O, Banchereau J, Capra JD. Analysis of somatic mutation in five B cell subsets of human tonsil. J Exp Med. 1994;180:329-339.
30. Pascual V, Wilson P, Liu YJ, Banchereau J, Capra JD. Biased VH4 gene segment repertoire in the human tonsil. Chem Immunol. 1997;67:45-57.
31. Wilson PC, de Bouteiller O, Liu YJ, et al. Somatic hypermutation introduces insertions and deletions into immunoglobulin V genes. J Exp Med. 1998;187:59-70.
32. Zhou C, Saxon A, Zhang K. Human activation-induced cytidine deaminase is induced by IL-4 and negatively regulated by CD45: implication of CD45 as a Janus kinase phosphatase in antibody diversification. J Immunol. 2003;170:1887-1893.
33. Muramatsu M. [AID controls immunoglobulin class switch recombination]. Seikagaku. 2006;78:719-724.
34. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 2000;102:553-563.
35. Muramatsu M, Sankaranand VS, Anant S, et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem. 1999;274:18470-18476.
36. Okazaki I, Yoshikawa K, Kinoshita K, Muramatsu M, Nagaoka H, Honjo T. Activation-induced cytidine deaminase links class switch recombination and somatic hypermutation. Ann N Y Acad Sci. 2003;987:1-8.
37. Jackson SM, Capra JD. IgH V-region sequence does not predict the survival fate of human germinal center B cells. J Immunol. 2005;174:2805-2813.
38. Testi R, Phillips JH, Lanier LL. Leu 23 induction as an early marker of functional CD3/T cell antigen receptor triggering. Requirement for receptor cross-linking, prolonged elevation of intracellular [Ca++] and stimulation of protein kinase C. J Immunol. 1989;142:1854-1860.
39. Cosulich ME, Risso A, Smilovich D, Baldissarro I, Capra MC, Bargellesi A. CD69 activation molecule: requirements for its expression on T cells. Pharmacol Res 1992;26 Suppl 2:136-138.
40. Neckers LM. Regulation of transferrin receptor expression and control of cell growth. Pathobiology. 1991;59:11-18.
41. Schwarting R, Gerdes J, Niehus J, Jaeschke L, Stein H. Determination of the growth fraction in cell suspensions by flow cytometry using the monoclonal antibody Ki-67. J Immunol Methods. 1986;90:65-70.
42. Zheng NY, Wilson K, Wang X, et al. Human immunoglobulin selection associated with class switch and possible tolerogenic origins for C delta class-switched B cells. J Clin Invest. 2004;113:1188-1201.
43. Ratech H, Denning S, Kaufman RE. An analysis of alternatively spliced CD45 mRNA transcripts during T cell maturation in humans. Cell Immunol. 1997;177:109-118.
44. National Center for Biotechnology Information. IgBlast database. Available at http://www.ncbi.nlm.nih.gov/igblast. Accessed 2006-2007.
45. Le Franc, M-P. IMGT/V-QUEST database. Available at http://imgt.cines.fr: 8104. Accessed 2006-2007.
46. Arpin C, de Bouteiller O, Razanajaona D, et al. The normal counterpart of IgD myeloma cells in germinal center displays extensively mutated IgVH gene, Cmu-Cdelta switch, and lambda light chain expression. J Exp Med. 1998;187:1169-1178.
47. Liu YJ, de Bouteiller O, Arpin C, et al. Normal human IgD+IgM- germinal center B cells can express up to 80 mutations in the variable region of their IgD transcripts. Immunity. 1996;4:603-613.
48. Blankenberg FG, Katsikis PD, Tait JF, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci U S A. 1998;95:6349-6354.
49. Dillon SR, Mancini M, Rosen A, Schlissel MS. Annexin V binds to viable B cells and colocalizes with a marker of lipid rafts upon B cell receptor activation. J Immunol. 2000;164:1322-1332.
50. McHeyzer-Williams LJ, Malherbe LP, McHeyzer-Williams MG. Helper T cell-regulated B cell immunity. Curr Top Microbiol Immunol. 2006;311:59-83.
51. William J, Euler C, Primarolo N, Shlomchik MJ. B cell tolerance checkpoints that restrict pathways of antigen-driven differentiation. J Immunol. 2006;176:2142-2151.
52. Brekelmans P, van Soest P, Voerman J, Platenburg PP, Leenen PJ, van Ewijk W. Transferrin receptor expression as a marker of immature cycling thymocytes in the mouse. Cell Immunol. 1994;159:331-339.
53. Muraguchi A, Kehrl JH, Butler JL, Fauci AS. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig. J Immunol. 1984;132:176-180.
54. Kimoto H, Nagaoka H, Adachi Y, et al. Accumulation of somatic hypermutation and antigen-driven selection in rapidly cycling surface Ig+ germinal center (GC) B cells which occupy GC at a high frequency during the primary anti-hapten response in mice. Eur J Immunol. 1997;27:268-279.
55. Liu YJ, Arpin C, de Bouteiller O, et al. Sequential triggering of apoptosis, somatic mutation and isotype switch during germinal center development. Semin Immunol. 1996;8:169-177.